Results
Norris Medicines Q1 FY27 Net Loss ₹39.68 Lakh
Norris Medicines reported a Q1 FY27 net loss of ₹39.68 lakh, a decline from a ₹5.06 lakh profit in Q4 FY26.
The Board approved the reappointment of Vimal D. Shah as Managing Director for a three-year
